Showing results (171-180 of 189) with videos related to
Sort By:
Pageof 19
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic SignificanceYan Zhu, Luisa Maren Solis Soto, Shubham Pant, et al.Science Signaling|March 5, 2024
eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancerWarapen Treekitkarnmongkol, Luisa M Solis, Deivendran Sankaran, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studiesLynette M Smith, Douglas W Mahoney, William R Bamlet, et al.Cancer Medicine|June 26, 2024
Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United StatesChristopher Shi, Brian De, Hop S Tran Cao, et al.American Journal of Hematology|January 2, 2023
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective studyBrian T Hess, Anshu Giri, Yeonhee Park, et al.Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.International Journal of Radiation Oncology, Biology, Physics|November 1, 2024
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 TrialJay P Reddy, Alexander D Sherry, Bryan Fellman, et al.Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.JAMA Oncology|April 7, 2022
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical TrialDaniel M Halperin, Suyu Liu, Arvind Dasari, et al.JAMA Oncology|April 6, 2023
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical TrialChad Tang, Alexander D Sherry, Cara Haymaker, et al.Pageof 19